Device Trial Radar · NCT05280093
HEAL-IST IDE Trial
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
100
Actual
Start
May 31, 2022
Primary completion
Feb 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- AtriCure, Inc.Public (ATRC)
- Sponsor type
- Industry
- First posted
- Mar 15, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.
Conditions
- Inappropriate Sinus Tachycardia
Interventions
AtriCure ISOLATOR Synergy Surgical Ablation SystemDevice
Hybrid sinus node sparing ablation procedure using the ISOLATOR Synergy Surgical Ablation System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness EndpointTime frame: 12-months Post Procedure
- Primary Safety EndpointTime frame: 30-days Post Procedure
Locations
27 sites in 6 countries. Site status is shown where the registry gives one.
St. Bernard
Jonesboro, Arkansas
Loma Linda University Health
Loma Linda, California
Sequoia Hospital
Redwood City, California
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.